Ablation Techniques. Bruce Braithwaite, Nottingham Queens
10.10
Compression Techniques. Andrea Nelson, Leeds
10.30
Coffee
11.00 – 12.20
Scientific Session 1: Ulcers
Chairmen: R Corbett, A Katsamouris
11.00
1.1
Excision and grafting in hard to heal leg ulcers Abisi S, Tan J, Burnand K. Academic Surgery Department, St Thomas’ Hospital, London, UK
(Pdf file)
11.20
1.2
A prospective randomised trial of ICX-PRO (cultured fibroblasts) in healing chronic leg ulcers Blair SD , Gawne S on behalf of Topical 1 trial participants. Wirral Hospital Trust, Upton, Wirral, UK
(Pdf file)
11.40
1.3
A world’s novelty: Venotrain micro balance combining compression therapy with effective skin care. A randomised, controlled, prospective, explorative study Junger M, Riebe H. Universitats-Hautklinik, Fleischmannstr 42-44, 17487 Greifswald, Germany
(Pdf file)
12.00
1.4
Prevention of recurrence of venous ulceration: Randomised controlled trial of class 2 and class 3 elastic compression Nelson EA (1,2), Harper DR (2,3), Gibson B (2,4), Prescott RJ (2,5), Ruckley CV (2). (1) University of Leeds, Leeds, UK, (2) Lothian and Forth Valley Leg Ulcer Study, Edinburgh and Falkirk, UK, (3) Aberdeen Royal Infirmary, Aberdeen, UK, (4) Falkirk and District Royal Infirmary, Falkirk, UK, (5) University of Edinburgh, Edinburgh, UK
(Pdf file)
12.20
Key Note Lecture: Ethnicity in Venous Disease. Andrew Bradbury, Birmingham
12.40
Lunch
13.40 – 15.40
Scientific Session 2: Outcomes
Chairmen: J Earnshaw, M Perrin
13.40
2.5
The clinical significance of persistent below-knee great saphenous vein (BK-GSV) reflux following endovenous GSV laser ablation (EVLA): Do we need to modifty treatment? Theivacumar N, Dellagrammaticas D, Mavor A, Gough M. Leeds Vascular Institute, The General Infirmary at Leeds, UK
(Pdf file)
14.00
2.6
Comparative analysis of usefulness of two scoring systems, CEAP and VSS, in assessment of CVD severity and outcome of surgical treatment Jawien A, Switonski M, Grzela T, Migdalski A, Piotrowicz R. Department of Surgery, Nicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Poland
(Pdf file)
14.20
2.7
Ulcerated leg severity assessment (ULSA) score: A new tool to predict healing in venous leg ulceration Kulkarni SR, Gohel MS, Wakeley C, Minor J, Taylor M, Poskitt KR, Whyman MR. Vascular Unit, Cheltenham General Hospital, Cheltenham, UK
(Pdf file)
14.40
2.8
Comparison of conventional stripping versus cyro-stripping: A prospective randomised trial Menyhei G, Gyevnar Z. Department of Vascular Surgery, University of Pecs, Hungary
(Pdf file)
15.00
2.9
Water: The ultimate sclerosing agent? Occlusion of varicose veins by in-situ generated superheated steam Milleret R (1), Mehier H (2), Foray J (2), Humbert S (2), Rauber N. (1) Vein Center, Montpellier, France, (2) Cerma, Archamps, France (Pdf file)
15.20
2.10
Varicose vein treatment and restoration of saphenous vein competence: The French “Asval” method Pittaluga P (1), Chastanet S (1), Rea B (2), Barbe R (2), Guex JJ (1). (1) Riviera Veine Institut, Nice, France, (2) Clinique Charcot, Lyon, France (Pdf file)
15.40
Tea
16.10 – 17.30
Scientific Session 3: Deep Venous Thrombosis
Chairmen: T Lees, J Fareed
16.10
3.11
Repeated failure of application of hospital DVT prophylaxis protocol: What is required to establish effective protocol compliance? Howard A, Williams A, Reise J, Brown L, Alvand A, Davies AH, Greenhalgh RM. Department of Vascular Surgery, Charing Cross Hospital, London, UK
(Pdf file)
16.30
3.12
Neovalve construction in postthrombotic syndrome and valve aplasia Lugli M, Maleti O. Department of Cardiovascular Surgery, Hesperia Hospita, Modena, Italy
(Pdf file)
16.50
3.13
Endovenous valve transfer stent (EVTS) for the treatment of chronic deep venous insufficiency Phillips M (1), Lane R (1), Cuzzilla M (1), Simmons A (2). (1) Department of Vascular Surgery, Royal North Shore Hospital,Sydney, Australia, (2) Graduate School of Biomedical Engineering, University of New South Wales, Sydney, Australia
(Pdf file)
17.10
3.14
Is failure to provide thromboprophylaxis negligent? Scurr JR, Scurr JH. The Lister Hospital, London, UK
(Pdf file)
17.30
Invited Lecture: Thrombosis in Venous Disease. Tom Wakefield
Invited papers.
Chairmen: M Callum, JJ Guex
17.50
The history of the iliac compression syndrome. JT Hobbs, UK
18.00
Endoluminal treatment of lower limb varicose veins by endovenous laser and
radiofrequency. A review of the literature as of 1 March 2006. M. Perrin, France
18.20
Therapeutic benefit of Daflon 500mg in the treatment of venous leg ulcers. P Coleridge-Smith, Lok C, Ramelet A-A
18.30
The future of venous disease - report from the Hawaiian Venous Summit January 2006, B. Eklof
18.50
Welcome Reception. Exhibition Area
Friday 30 June 2006
06.30
Registration
North Hall
07.00 – 08.30
Breakfast Session – Biolitec ELVeS Meeting:
Up-date on Endovenous Laser Oblitation
Chairman: Alun Davies
07.30
Laser and technology on ELVeS. Martin Sabado ( UK)
07.45
ELVeS for the great saphenous vein. Joe Brookes ( UK)
08.00
ELVeS for the short saphenous vein. Results. Michael Gough ( UK)
08.15
Treatment of reticular vein and branches. Giuseppe Serpieri ( Italy)
08.30
The future of ELVeS. Vein ulcer treatment. David Greenstein ( UK)
08.45
Conclusions and Discussions
New Lecture Theatre
09.00-10.00
“Interesting Cases”
Chairmen: J Hobbs, P Zamboni
09.00
A difficult diagnostic problem. Nicos Labropoulos, USA
09.15
Pagets Syndrome. Gerry Stansby, Newcastle
09.30
Mesenteric vein thrombosis. George Geroulakos, London
09.45
Recurrent varicose veins. Jonothan Earnshaw
10.00
Coffee
10.30 – 12.30
Scientific Session 4: Venous Diseases
Chairmen: T Wakefield, M Kurtoglu
10.30
4.15
Venous hypertension induced venous insufficiency ameliorated by Daflon 500mg Pascarella L (1), Lulic D (2), Alsaigh T (1), Lee J (1), Kapur V (1), Schmid-Schonbein G (1), Bergan J (2). (1) Department of Bioengineering, (2), Department of Surgery, UCSD School of Medicine, San Diego, California, USA
(Pdf file)
10.50
4.16
Role of TIMP-3 in causation of varicose veins Sharp B (1), Aravind B (1), Navin T (2), Monaco C (2), Paleolog E (2), Davies AH (1). (1) Charing Cross Hospital, London, UK, (2) Kennedy Institute of Rheumatology, Imperial College, London, UK
(Pdf file)
11.10
4.17
Local anaesthesia for varicose vein stripping Simms M, Mortimer J, Butterly S, Sargent B, Dealey C. Selly Oak Hospital, University Trust, Birmingham, UK
(Pdf file)
11.30
4.18
The profiles of MMP-1, -2, -8, -9 and TIMP-1 in chronic venous ulcers Tan J, Abisi S, Smith A, Sawyer B, Eastham D, Burnand K. Academic Department of Surgery, Cardiovascular Division, St Thomas’ Hospital, 1 st floor, North Wing, Lambeth Palace Road, London, UK
(Pdf file)
11.50
4.19
A patient self-administered quality of life questionnaire to complement clinical and vascular laboratory assessments of varicose veins Van Rij AM, Chen T, Macfarlane J, Landmann MC. Department of Surgery, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand
(Pdf file)
12.10
4.20
Elevated lipoprotein (a) levels: A new biological marker of venous thromboembolic risk Casals F (1,2), Escolar G (1,2), Deulofeu R (1,3). (1) Thromboembolism Unit (EFMATE), (2) Hemotherapy-Hemostase Dept, (3) Lipids Laboratory, CBD, Hospital Clinic, Barcelona, Spain
(Pdf file)
12.30
Lunch
13.30-15.30
DVT Prophylaxis – which modality, when?
(Supported by an educational grant from Tyco Healthcare)
Chairman: Alun Davies
13.30
DVT – an underestimated problem. Alun Davies, UK
13.50
Pharmacological prophylaxis. Beverley Hunt, UK
14.10
Mechanical prophylaxis. Jana Naef, USA
14.30
Combined modalities. Joe Caprini, USA
14.50
Cost effectiveness of DVT prophylaxis. Andrew Nicolaides, Cyprus
15.10
Discussion
15.30
Tea
16.00
Invited Lecture: Outcome Measures in Venous Disease. Greg Moneta, USA
16.30-17.10
Servier Travelling Fellowship Award Winners
Chairmen: B Eklof, J Wolfe
16.30
21
Open endophlebectomy and endovenous stenting for chronic thrombosis of the inferior vena cava and the iliofemoral veins Oderich GS, Noel AA, Bjarnasson H, Sheilds RC, Rooke TW, Kalra M, Gloviczki P. Mayo Clinic, Rochester, MN, USA
(Pdf file)
16.50
22
The use of D-dimer and pretest clinical probability to determine the need for duplex ultrasonography in the diagnosis of deep venous thrombosis Stonerock CE, Pandurangi K, Dalsing MC. Indiana University School of Medicine, Department of Vascular Surgery, Indianapolis, IN, USA (Pdf file)
17.10-17.30
EVF Invited Lecture: Thrombolysis in Venous Disease. Anthony Comerota, USA
17.30 – 18.00
The Potential of a Venous Registry
Speakers: Mariella Catalano, Italy, Tim Lees, UK
18.00-18.30
ANNUAL GENERAL MEETING
19.30
Conference Dinner. Langhams Hotel
Saturday 1 July 2006
08.30
Registration
New Lecture Theatre
09.00
Invited Lecture: Inflammation in venous disease. Paolo Zamboni, Italy
09.30 – 10.50
Scientific Session 5: Techniques of venous ablation
Chairmen: P Lamont, M Vandendriessche
09.30
5.23
Stripping vs haemodynamic correction (CHIVA): A long term randomised trial Carandina S, Mari C, De Palma M, Marcellino MG, Legnaro A, Liboni A, Zamboni P. Department of Surgery, Day Surgery Unit, University of Ferrara, Ferrara, Italy
(Pdf file)
09.50
5.24
Foam injection sclerotherapy cures veins with a single injection: Fact or fiction Forlee MV, Dowdall JF, Haider SN, McDonnell CO, Nyheim T, Malik C, Colgan MP, Madhavan P, Moore DJ, Shanik GD. St James’s Vascular Institute, St James’s Hospital, Dublin, Ireland
(Pdf file)
10.10
5.25
Disease severity scores for varicose veins: Their reliability in assessing the outcome of endovenous laser ablation (EVLA) and recommendations for future studies Theivacumar N, Dallagrammaticas D, Beale R, Mavor A, Gough M. Leeds Vascular Institute, General Infirmary at Leeds, Leeds, UK
(Pdf file)
10.30
5.26
Surgical treatment of varicose veins: Comparative study between two different techniques Iborra E, Vila R, Barjau E, Cairols MA. Servei d’Angiologia I Cirurgia Vascular, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Spain
(Pdf file)
10.50
Coffee
11.20 – 13.20
Scientific Session 6: Imaging and Management
Chairmen: G Stansby, A Comerota
11.20
6.27
Ultrasonic venous valve imaging – a prerequisite for existent repair Cuzzilla M (1), Lane R (1), Phillips M (1), Graiche J (2), Coroneos J (3). (1) Department of Vascular Surgery, Royal North Shore Hospital, Sydney, Australia, (2) North Shore Vein Clinic, Sydney, Australia, (3) Dalcross Private Hospital, Sydney, Australia
(Pdf file)
11.40
6.28
Surgical solution of the enigma of the gastrocnemius vein De Palma M, Carandina S, Zamboni P. Department of Surgery and Vascular Diseases Center, University of Ferrara, Italy
(Pdf file)
12.00
6.29
Continuous ambulatory venous pressure monitoring. A step forward in quantifying venous reflux Eifell RKG (1), Ashour HY (1), Lees TA (2). (1) Department of Surgery, Queen Elizabeth Hospital, Gateshead, (2) Northern Vascular Centre, Freeman Hospital, Newcastle upon Tyne, UK
(Pdf file)
12.20
6.30
Comparison of three intermittent pneumatic compression systems in patients with varicose veins: A haemodynamic study Griffin M, Kakkos SK, Nicolaides AN, Geroulakos G. Department of Vascular Surgery, Imperial College and Ealing Hospital, London, UK (Pdf file)
12.40
6.31
Short and mid-term evolution of isolated symptomatic muscular calf vein thrombosis Gillet J-L (1), Perrin MR (2), Allaert FA (3). (1) Vascular Medicine, Bourgoin-Jallieu, France, (2) Vascular Surgery, Chassieu, France, (3) Dept Biostatistics Cenbiotech, Dijon, France
(Pdf file)
13.00
6.32
A reproducibility study on the immediate hemodynamic effect of the additional use of the SCD Express compression system in patients with venous ulcers treated with the four-layer compression bandaging system Kalodiki E, Ellis M, Kakkos SK, Williams A, Davies AH, Geroulakos G. Department of Vascular Surgery, Charing Cross Hospital, Imperial College, London, UK
(Pdf file)
13.20
Lunch
14.20-15.30
Sclerotherapy Session
Chairmen: Marianne Vandendriessche, Philip Coleridge-Smith
14.20
Sclerotherapy for small varices: technique and efficacy. Marianne Vandendiressche (Belgium)
14.35
Surgeon turned sclerotherapist: poacher turned gamekeeper? Andrew Bradbury (UK)
14.50
Foam sclerotherapy for saphenous varices. Attilio Cavezzi (Italy)
15.05
Outcomes of ultrasound guided foam sclerotherapy. Philip Coleridge-Smith (UK)
